rs74615166
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_016213.5(TRIP4):c.1575+7660T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0157 in 152,250 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.016 ( 25 hom., cov: 32)
Consequence
TRIP4
NM_016213.5 intron
NM_016213.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.328
Publications
16 publications found
Genes affected
TRIP4 (HGNC:12310): (thyroid hormone receptor interactor 4) This gene encodes a subunit of the tetrameric nuclear activating signal cointegrator 1 (ASC-1) complex, which associates with transcriptional coactivators, nuclear receptors and basal transcription factors to facilitate nuclear receptors-mediated transcription. This protein is localized in the nucleus and contains an E1A-type zinc finger domain, which mediates interaction with transcriptional coactivators and ligand-bound nuclear receptors, such as thyroid hormone receptor and retinoid X receptor alpha, but not glucocorticoid receptor. Mutations in this gene are associated with spinal muscular atrophy with congenital bone fractures-1 (SMABF1). [provided by RefSeq, Apr 2016]
TRIP4 Gene-Disease associations (from GenCC):
- prenatal-onset spinal muscular atrophy with congenital bone fracturesInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- spinal muscular atrophy with congenital bone fractures 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0157 (2397/152250) while in subpopulation SAS AF = 0.0247 (119/4820). AF 95% confidence interval is 0.0211. There are 25 homozygotes in GnomAd4. There are 1208 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRIP4 | NM_016213.5 | c.1575+7660T>C | intron_variant | Intron 11 of 12 | ENST00000261884.8 | NP_057297.2 | ||
| TRIP4 | NM_001321924.2 | c.885+7660T>C | intron_variant | Intron 11 of 12 | NP_001308853.1 | |||
| TRIP4 | NR_135855.2 | n.1476+7660T>C | intron_variant | Intron 10 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRIP4 | ENST00000261884.8 | c.1575+7660T>C | intron_variant | Intron 11 of 12 | 1 | NM_016213.5 | ENSP00000261884.3 | |||
| TRIP4 | ENST00000558162.1 | c.132+7660T>C | intron_variant | Intron 2 of 3 | 3 | ENSP00000452764.1 | ||||
| TRIP4 | ENST00000560475.1 | c.111-11715T>C | intron_variant | Intron 1 of 2 | 3 | ENSP00000454558.1 |
Frequencies
GnomAD3 genomes AF: 0.0158 AC: 2403AN: 152132Hom.: 26 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2403
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0157 AC: 2397AN: 152250Hom.: 25 Cov.: 32 AF XY: 0.0162 AC XY: 1208AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
2397
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
1208
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
163
AN:
41560
American (AMR)
AF:
AC:
241
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5174
South Asian (SAS)
AF:
AC:
119
AN:
4820
European-Finnish (FIN)
AF:
AC:
321
AN:
10614
Middle Eastern (MID)
AF:
AC:
10
AN:
292
European-Non Finnish (NFE)
AF:
AC:
1482
AN:
68012
Other (OTH)
AF:
AC:
48
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
119
238
358
477
596
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
32
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.